Please visit answersincme.com/CUA860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in rheumatology discusses treatment options for non-radiographic axial spondyloarthritis (nr-axSpA). Upon completion of this activity, participants should be better able to: Recognize guideline-recommended treatment options used to reduce the burden of non-radiographic axial spondyloarthritis (nr-axSpA) on patients; Describe the clinical impact of approved and late-stage emerging agents for the treatment of nr-axSpA; and Outline clinical considerations for the role of approved and late-stage emerging agents in the treatment landscape of nr-axSpA.